MoneyWorks4Me

Guj. Themis Biosyn reports Profit after tax of Rs 186.99 Mln, in the September 2022 quarter

07 Nov 2022 Evaluate
A decent increase of about 36.08% in the sales to Rs. 476.91 millions was observed for the quarter ended September 2022. The sales figure stood at Rs. 350.47 millions during the year-ago period.The company has announced a 35.59% increase in its profits to Rs . 186.99  millions for the  quarter ended September 2022 compared to Rs. 137.91 millions in the corresponding quarter in the previous year.Operating Profit saw a handsome growth to 257.98 millions from 191.60 millions in the quarter ended September 2022.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202209 202109 % Var 202209 202109 % Var 202203 202103 % Var
Sales 476.91 350.47 36.08 926.35 674.87 37.26 1148.54 905.63 26.82
Other Income 13.96 7.15 95.24 28.19 18.48 52.54 40.50 32.67 23.97
PBIDT 257.98 191.60 34.65 500.00 370.17 35.07 620.95 435.95 42.44
Interest 0.42 1.26 -66.67 1.04 3.22 -67.70 8.28 9.81 -15.60
PBDT 257.56 190.34 35.32 498.96 366.95 35.97 612.67 426.14 43.77
Depreciation 5.79 5.77 0.35 11.49 11.18 2.77 22.33 17.32 28.93
PBT 251.77 184.57 36.41 487.47 355.77 37.02 590.34 408.82 44.40
TAX 64.78 46.66 38.83 122.77 88.63 38.52 154.10 107.02 43.99
Deferred Tax 2.66 0.18 1377.78 0.74 -0.24 -408.33 0.72 1.26 -42.86
PAT 186.99 137.91 35.59 364.70 267.14 36.52 436.24 301.80 44.55
Equity 72.64 72.64 0.00 72.64 72.64 0.00 72.64 72.64 0.00
PBIDTM(%) 54.09 54.67 -1.05 53.98 54.85 -1.60 54.06 48.14 12.31
Peers
Company Name CMP
Sun Pharma. Inds. 1783.25
Dr. Reddys Labs. 1202.40
Cipla 1329.50
Lupin 2007.10
Zydus Lifesciences 1154.00
View more..